APOLLOMICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4132 USD | +2.66% |
|
-1.38% | -57.18% |
| May. 08 | Apollomics, Inc. Appoints Robert Lin to the Board of Directors | CI |
| May. 08 | Apollomics, Inc. announced that it has received $5.75 million in funding | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 130 | 139.1 | 86.4 | 36.98 | - | - |
| Enterprise Value (EV) 1 | 130 | 139.1 | 86.4 | 36.98 | 36.98 | 36.98 |
| P/E ratio | -43.2 x | -16.7 x | -0.42 x | -0.65 x | -0.47 x | -0.34 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | 26.8 x | 74 x | 37 x | - |
| EV / Revenue | - | - | 26.8 x | 74 x | 37 x | - |
| EV / EBITDA | - | -3.12 x | -1.56 x | -0.88 x | -0.48 x | -0.29 x |
| EV / FCF | - | - | - | -0.65 x | -0.4 x | -0.25 x |
| FCF Yield | - | - | - | -153% | -253% | -396% |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 13,090 | 13,428 | 89,531 | 89,496 | - | - |
| Reference price 2 | 9.930 | 10.36 | 0.9650 | 0.4132 | 0.4132 | 0.4132 |
| Announcement Date | 9/29/22 | 4/28/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | 3.229 | 0.5 | 1 | - |
| EBITDA 1 | - | -44.63 | -55.36 | -42.1 | -76.6 | -126.6 |
| EBIT 1 | - | -45.4 | -56.02 | -60.28 | -92.3 | -145.3 |
| Operating Margin | - | - | -1,735.06% | -12,055.5% | -9,230% | - |
| Earnings before Tax (EBT) 1 | - | -240.8 | -172.6 | -62.98 | -94.7 | -145.3 |
| Net income 1 | -94.8 | -240.8 | -172.6 | -62.98 | -94.7 | -145.3 |
| Net margin | - | - | -5,345.34% | -12,595.5% | -9,470% | - |
| EPS 2 | -0.2300 | -0.6200 | -2.320 | -0.6350 | -0.8700 | -1.220 |
| Free Cash Flow 1 | - | - | - | -56.5 | -93.5 | -146.5 |
| FCF margin | - | - | - | -11,300% | -9,350% | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/29/22 | 4/28/23 | 3/28/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|
| Net sales 1 | - | - | - | - |
| EBITDA | - | - | - | - |
| EBIT 1 | -15.5 | -16.06 | -16.58 | -17.12 |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | -15.5 | -16.06 | -16.58 | -17.12 |
| Net income 1 | -15.5 | -16.06 | -16.58 | -17.12 |
| Net margin | - | - | - | - |
| EPS 2 | -0.1700 | -0.1800 | -0.1600 | -0.1400 |
| Dividend per Share | - | - | - | - |
| Announcement Date | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | - | - | - | -56.5 | -93.5 | -147 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex 1 | - | 0.37 | - | 2.1 | 2.1 | 2.1 |
| Capex / Sales | - | - | - | 420% | 210% | - |
| Announcement Date | 9/29/22 | 4/28/23 | 3/28/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.4132
USD
Average target price
5.75
USD
Spread / Average Target
+1,291.58%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -57.18% | 36.98M | |
| +2.93% | 108B | |
| -1.95% | 23.46B | |
| -14.60% | 21.72B | |
| -7.05% | 18.64B | |
| -38.55% | 17.45B | |
| -8.83% | 17.19B | |
| +5.51% | 13.99B | |
| +37.49% | 12.53B | |
| +329.39% | 8.81B |
- Stock Market
- Equities
- APLM Stock
- Financials Apollomics, Inc.